SCHEMBL15260941

SCHEMBL15260941

COc1ccc(Cn2cc3c(n2)CC(C)Cc2sc(N)nc2-3)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AADAT Q8N5Z0 1/20 0.42
ADORA1 P30542 6/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MPI P34949 1/20 0.41
DRD2 P14416 1/20 0.38
KCNH2 Q12809 1/20 0.38
LTA4H P09960 1/20 0.34
ACHE P22303 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
HRH2 P25021 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837318 0.84 ALDH1A1 (0.47) AADATADORA1MAPTALDH1A1KDM4E
SCHEMBL6837211 0.83 ADORA1 (0.42) AADATADORA1MAPTALDH1A1KDM4E
SCHEMBL369225 0.80 MAPT (0.45) AADATMAPTALDH1A1ACHELMNA
SCHEMBL371000 0.79 KDM4E (0.45) AADATADORA1MAPTALDH1A1KDM4E
SCHEMBL369405 0.79 GRM4 (0.40) AADATMAPTALDH1A1KDM4EACHE
SCHEMBL368608 0.78 ADORA1 (0.40) AADATADORA1MAPTALDH1A1KDM4E
SCHEMBL6837465 0.78 AADAT (0.39) AADATADORA1MAPTALDH1A1KDM4E
SCHEMBL367046 0.78 KDM4E (0.46) AADATADORA1MAPTALDH1A1KDM4E
SCHEMBL29191609 0.77 AADAT (0.51) AADATALDH1A1LMNAHPGDMEN1
SCHEMBL29191592 0.77 AADAT (0.51) AADATALDH1A1LMNAHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130252944-A1 NOVEL FUSED PYRAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK SHARP & DOHME CORP. 2013-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130252944-A1 NOVEL FUSED PYRAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM4, GRM1, GRM3 AADAT 837/4885ADORA1 152/4885MAPT 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.